Zivo Bioscience, Inc. Update: Major Changes Ahead

I’ve been tracking recent filings from Zivo Bioscience, and there is significant news you need to know. The company is making major shifts in how it operates. Here is the plain-English breakdown of what this means for your investment.

1. What is happening?

Zivo Bioscience is "going dark." On March 27, 2026, the company announced plans to stop filing regular financial reports with the SEC and voluntarily delist their stock and warrants from the OTCQB Venture Market. You will no longer be able to trade the stock on major public exchanges. Instead, the stock will move to the "Pink Sheets," where it will be significantly harder to buy or sell.

2. The Timeline

The company announced its intent to file a "Form 15" on March 27, 2026. This filing takes effect around April 6, 2026. Once effective, the company is no longer legally required to report its financial status to the SEC.

3. Why are they doing this?

The company is looking to cut costs. They currently spend between $500,000 and $750,000 every year on legal, audit, and compliance fees just to stay public. Zivo’s board decided these costs are too high for their current cash reserves. By deregistering, they hope to save that money to fund their core business: selling algal biomass for poultry gut health and developing human health supplements.

4. Why this matters for you

This is a massive change for shareholders for two main reasons:

• Transparency: You will lose access to audited financial reports. You will no longer be able to track how quickly the company spends its cash, which is a critical metric for a biotech firm.
• Liquidity: By leaving the OTCQB, the company removes the marketplace that makes trading easy. The stock will be much harder to trade, and many retail brokerage accounts may stop allowing you to buy or sell these shares entirely.

5. What happens next?

After the Form 15 is finalized, Zivo stops filing annual and quarterly reports. The company will essentially operate like a private business. They may provide updates if and when they choose, but these will likely be press releases that lack the depth and legal accountability of official SEC filings.

6. What should you do?

If you are currently holding Zivo stock, here is how to think about your next steps:

• Proceed with caution: This is a major red flag. It suggests the company is prioritizing immediate survival over public transparency.
• Re-evaluate your goals: If you invested because you wanted easy access to financial data or the ability to exit your position quickly, those conditions no longer exist.
• Expect to be "flying blind": If you stay invested, you won't be able to verify if the company is generating enough revenue to survive, or if they are burning through cash at a rate that might force them to issue more shares—which would dilute your ownership.

Bottom Line: This move significantly increases the risk profile of your investment. Before deciding to hold, ask yourself if you are comfortable owning a company that is no longer required to share its financial "report card" with the public.